NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biostate AI

Biostate AI

Private
Houston, TexasHealthcare & Life Scienceshttps://www.biostate.ai/

Last Round

Series A

May 20, 2025

Total Funding Raised

$16M

Company Overview

Biostate AI is a biotechnology company that provides a platform for RNA sequencing and develops generative artificial intelligence models to predict disease and drug response.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision medicineimmunotherapyRNA sequencingmulti-omicsAI drug discoveryimmune checkpoint inhibitorspredictive modelingbiotech AIAI scientistdata as a serviceDaaStherapeutic optimizationin silico drug discoveryAI-native biotechclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biostate AI Comps

Public and private peers based on sector, stage, and business model.

Biostate AI comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biostate AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 20, 2025
SeedJul 9, 2024

Biostate AI Investors

Notable investors and investment history

Biostate AI investors
InvestorRounds
Yuanjing CapitalSeed, Series A
GaingelsSeries A
Mana VenturesSeries A
Catapult VCSeed
California Institute of Technology Investment OfficeSeed
Matter Venture PartnersSeries A, Seed
Catapult VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2025

    Developing AI models for melanoma immunotherapy with Mass General Brigham.

  • Jul 25, 2025

    Partnering with Mass General Brigham on AI for melanoma immunotherapy.

Biostate AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biostate AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biostate AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range26
Year Founded2023
Last FundingMay 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.